Your browser doesn't support javascript.
loading
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
Guo, Wancheng; Zhan, Yihao; Mery, David; Siegel, Eric R; Sun, Fumou; Cheng, Yan; Ashby, Timothy Cody; Zhang, Zijun; Bailey, Clyde; Alapat, Daisy V; Peng, Hongling; Hadidi, Samer Al; Thanendrarajan, Sharmilan; Schinke, Carolina; Zangari, Maurizio; van Rhee, Frits; Tricot, Guido; Shaughnessy, John D; Zhan, Fenghuang.
Afiliação
  • Guo W; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zhan Y; Department of Haematology, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, China.
  • Mery D; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Siegel ER; Department of Haematology, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, China.
  • Sun F; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Cheng Y; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Ashby TC; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zhang Z; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Bailey C; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Alapat DV; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Peng H; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Hadidi SA; Department of Pathology Clinical, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Thanendrarajan S; Department of Haematology, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, China.
  • Schinke C; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zangari M; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • van Rhee F; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Tricot G; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Shaughnessy JD; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zhan F; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Blood Cancer J ; 14(1): 30, 2024 02 14.
Article em En | MEDLINE | ID: mdl-38355688

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article